5 investors at Versant Ventures, based in San Francisco, CA with $3.3B under management.
Back to Versant Ventures profile
Chairman, Managing Director, Versant Ventures
Brad Bolzon combines 13 years of senior R&D and business development experience at Eli Lilly and Roche with his role as architect of Versant's cross-border company-creation strategy, including co-founding Inception Sciences as a shared discovery platform that spins out multiple biotech startups. He has served as founding chairman or long-term board leader at flagship companies like CRISPR Therapeutics for over a decade, while building Versant's multi-hub presence across the US, Canada, and Europe.
Managing Director, Versant Ventures
Brad Bolzon combines 13 years of senior R&D and business development experience at Eli Lilly and Roche with his role as architect of Versant's cross-border company-creation strategy, including co-founding Inception Sciences as a shared discovery platform that spins out multiple biotech startups. He has served as founding chairman or long-term board leader at flagship companies like CRISPR Therapeutics for over a decade, while building Versant's multi-hub presence across the US, Canada, and Europe.
Managing Director, Versant Ventures
Brad Bolzon combines 13 years of senior R&D and business development experience at Eli Lilly and Roche with his role as architect of Versant's cross-border company-creation strategy, including co-founding Inception Sciences as a shared discovery platform that spins out multiple biotech startups. He has served as founding chairman or long-term board leader at flagship companies like CRISPR Therapeutics for over a decade, while building Versant's multi-hub presence across the US, Canada, and Europe.
Managing Director/Advisor, Versant Ventures
Brad Bolzon combines 13 years of senior R&D and business development experience at Eli Lilly and Roche with his role as architect of Versant's cross-border company-creation strategy, including co-founding Inception Sciences as a shared discovery platform that spins out multiple biotech startups. He has served as founding chairman or long-term board leader at flagship companies like CRISPR Therapeutics for over a decade, while building Versant's multi-hub presence across the US, Canada, and Europe.
Managing Director, Versant Ventures
Brad Bolzon combines 13 years of senior R&D and business development experience at Eli Lilly and Roche with his role as architect of Versant's cross-border company-creation strategy, including co-founding Inception Sciences as a shared discovery platform that spins out multiple biotech startups. He has served as founding chairman or long-term board leader at flagship companies like CRISPR Therapeutics for over a decade, while building Versant's multi-hub presence across the US, Canada, and Europe.
Newsletter
Join thousands of founders and investors. Every Tuesday.